OpenAI’s investment highlights the intensifying race in neurotechnology, where Neuralink (led by Elon Musk) currently leads ...

Reinforcement learning frames trading as a sequential decision-making problem, where an agent observes market conditions, ...

So if we’re right, each former human is now essentially a radio transmitter and receiver. One plurb sends out a signal that ...

As President Trump approaches one year back in office, the policies his administration pursues — and how those policies are ...

OpenAI says ads will not influence ChatGPT’s responses, and that all ads will appear in separate, clearly labeled boxes directly below the chatbot’s answer. For instance, if a user asks ChatGPT for ...

The way we see it, 2026 is going to be a monumental battle with AI for the music industry’s soul. As it seemingly seeps into ...

YD Bio entered a memorandum of understanding to merge with EG BioMed in a combination intended to advance DNA methylation-driven AI platforms for cancer diagnostics and drug development. The ...

A multiyear legal skirmish between two 3D fashion technology providers has come to an end, with a Chinese court ruling that ...

Since the clock struck midnight on January 1, 2026, the internet has embarked on a mission to make 2026 the new 2016, ...

YD Bio Limited ('YD Bio” or the 'Company”) (Nasdaq: YDES), a biotechnology company advancing DNA methylation-based cancer ...

So, M&A in fintech. It’s been a bit of a rollercoaster, right? Things are changing fast, and keeping up can feel like trying ...